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Robustness is a feature of regulatory pathways to ensure signal consistency in light of
environmental changes or genetic polymorphisms. The retinoic acid (RA) pathway, is a
central developmental and tissue homeostasis regulatory signal, strongly dependent on
nutritional sources of retinoids and affected by environmental chemicals. This pathway
is characterized by multiple proteins or enzymes capable of performing each step
and their integration into a self-regulating network. We studied RA network robustness
by transient physiological RA signaling disturbances followed by kinetic transcriptomic
analysis of the recovery during embryogenesis. The RA metabolic network was identified
as the main regulated module to achieve signaling robustness using an unbiased pattern
analysis. We describe the network-wide responses to RA signal manipulation and found
the feedback autoregulation to be sensitive to the direction of the RA perturbation:
RA knockdown exhibited an upper response limit, whereas RA addition had a minimal
feedback-activation threshold. Surprisingly, our robustness response analysis suggests
that the RA metabolic network regulation exhibits a multi-objective optimization, known
as Pareto optimization, characterized by trade-offs between competing functionalities.
We observe that efficient robustness to increasing RA is accompanied by worsening
robustness to reduced RA levels and vice versa. This direction-dependent trade-off
in the network-wide feedback response, results in an uneven robustness capacity
of the RA network during early embryogenesis, likely a significant contributor to the
manifestation of developmental defects.
Keywords: embryo development, time-series transcriptomics, temporal gene expression pattern analysis,
developmental trajectory analysis, autoregulatory feedback control, Pareto optimization, Xenopus embryo,
retinoic acid

Abbreviations: COMPACT, Comparative Matrix of Pattern Counts; DEAB, 4-diethylaminobenzaldehyde; PCA, Principal
Component Analysis; PCR, Polymerase Chain Reaction; RA, retinoic acid; WGCNA, Weighted Gene Coexpression Network
Analysis.
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changing conditions is termed robustness (Eldar et al., 2004;
Nijhout et al., 2019).
Over the years, multiple reports have supported the selfregulation of relatively few RA metabolic and signaling network
components by RA itself. Among the network component
genes shown to be responsive to RA levels, is aldh1a2 whose
expression has been shown to be down-regulated by increasing
RA, in somite stage zebrafish embryos, neurula stage Xenopus
embryos, and adult human epidermal cultures, or downregulated or insensitive in mouse 8.5 dpc embryos, among
others (Niederreither et al., 1997; Moss et al., 1998; Chen
et al., 2001; Dobbs-McAuliffe et al., 2004; Pavez Loriè et al.,
2009). The RA hydroxylase, CYP26A1, whose expression is
commonly adjacent to the site of ALDH1A2 expression and
RA production has also been studied (Hollemann et al., 1998;
Moss et al., 1998). RA up-regulation of the cyp26a1 gene
has been described in late gastrula Xenopus and zebrafish
embryos, cranial up-regulation and caudal down-regulation in
8.5 and 9.5 dpc mouse embryos, human hepatocytes, and others
(Fujii et al., 1997; Hollemann et al., 1998; Moss et al., 1998;
Dobbs-McAuliffe et al., 2004; Topletz et al., 2015). Another
important enzyme pair in RA metabolism commonly compared
are DHRS3 and RDH10 which preferentially reduce RAL to
ROL or oxidize ROL to RAL, respectively. RA up-regulation
of dhrs3 was observed in late gastrula Xenopus embryos, while
rdh10 showed no change in chick and was down-regulated in
Xenopus, both in neurula stage embryos (Strate et al., 2009;
Reijntjes et al., 2010; Kam et al., 2013). Few studies have
analyzed the effects of RA on the expression of other enzymes
in the RA metabolic network. While these observations support
an RA-dependent self-regulatory network, the multitude of
experimental systems, range of developmental stages, and RA
concentrations employed preclude the detailed understanding of
the self-regulation of the RA network.
Many of the studies showing RA regulation of components
of the RA metabolic network relied mainly on very high, nonphysiological and continued exposures to excess RA, and fewer
studies employed a reduction of RA. These studies, although
performed in different experimental systems, anatomical regions,
developmental stages, and even under different experimental
conditions, have led to insights on the self-regulation of the RA
metabolic and signaling network. These studies provided initial
understanding of the RA signaling robustness. However, the
extent to which fluctuations in RA lead to network-wide feedback
responses has not been investigated in-depth, including the limits
of robustness possible. The common use of supraphysiological
levels of RA to test the response of the embryo is largely due
to the common observation that embryonic malformations are
mild in response to fluctuations in RA within the physiological
range (Durston et al., 1989; Sive et al., 1990; Kessel, 1992).
RA knockdown studies taking advantage of inhibitors, inverse
agonists, or enzymatic degradation (Hollemann et al., 1998;
Kot-Leibovich and Fainsod, 2009; Janesick et al., 2014, 2013),
revealed that the developmental malformations observed were
usually mild compared to excess RA (Blumberg et al., 1997;
Sharpe and Goldstone, 1997; Hollemann et al., 1998; Koide
et al., 2001; Janesick et al., 2014; Shabtai et al., 2018).

INTRODUCTION
Robustness is an important feature of regulatory pathways to
ensure signal consistency in light of environmental changes
or genetic polymorphisms. Retinoic acid (RA), a central
regulatory signaling pathway active during embryogenesis
and adult tissue homeostasis (le Maire and Bourguet, 2014;
Metzler and Sandell, 2016), is synthesized from vitamin A
(retinol, ROL) or other retinoids or carotenoids obtained from
the diet (Blaner et al., 2016; Kedishvili, 2016; Fainsod and
Kot-Leibovich, 2018; Ghyselinck and Duester, 2019). During
embryogenesis, excessive or reduced RA signaling induces a
wide array of embryonic malformations (Durston et al., 1989;
Sive et al., 1990; Kessel and Gruss, 1991; Papalopulu et al.,
1991; Marshall et al., 1992; Hollemann et al., 1998; Corcoran
et al., 2002; Fainsod et al., 2020). Human disorders like vitamin
A deficiency syndrome, DiGeorge syndrome, Fetal Alcohol
Spectrum Disorder, Congenital Heart Disease, neural tube
defects, and multiple types of cancer have been linked to reduced
RA signaling (Kim et al., 2005; See et al., 2008; Urbizu et al.,
2013; Pangilinan et al., 2014; Hartomo et al., 2015; Fainsod et al.,
2020). RA levels are tightly regulated throughout life, controlling
quantitative, spatiotemporal expression and activity of the RA
metabolic network (Kedishvili, 2016; Blaner, 2019; Ghyselinck
and Duester, 2019). The regulatory mechanisms that confer this
tight regulation under constant environmental challenges, i.e.,
robustness, as well as conditions under which such mechanisms
fail, are yet to be fully understood.
Retinoic acid biosynthesis involves two sequential oxidation
steps: first, mainly, multiple alcohol dehydrogenases (ADH)
or short-chain dehydrogenase/reductases (SDR) can oxidize
ROL to retinaldehyde (RAL), followed by a subfamily of
aldehyde dehydrogenases, retinaldehyde dehydrogenases
(RALDH; ALDH1A) that catalyze the oxidation of RAL to
RA (Kedishvili, 2016; Metzler and Sandell, 2016; Ghyselinck
and Duester, 2019). ROL and RAL can also be produced from
retinyl esters or ß-carotene from food sources (Blaner, 2019).
RA availability is further regulated by several ROL, RAL, and
RA binding proteins (Napoli, 2017). In gastrula vertebrate
embryos, RA signaling is triggered by the initial expression
of ALDH1A2 (RALDH2) completing the biosynthesis of RA
(Niederreither et al., 1999; Begemann et al., 2001; Chen et al.,
2001; Grandel et al., 2002; Shabtai et al., 2018). Substrate
availability for the RALDH enzymes is controlled by multiple
RAL reductases (Feng et al., 2010; Billings et al., 2013; Porté
et al., 2013; Adams et al., 2014; Shabtai and Fainsod, 2018).
Besides the temporal and spatial regulation of this wide array
of RA metabolic network components, other RA network
components, including the RA receptor families (RAR and
RXR) and retinoid-binding proteins (Lohnes et al., 1995; Cui
et al., 2003; Janesick et al., 2015) are under tight regulation.
The RA signal is sensitive to the maternal nutritional status
and environmental exposure to chemicals (ethanol and
others) (Paganelli et al., 2010; Shabtai et al., 2018), requiring
the necessity to adapt the RA biosynthetic and signaling
network to nutritional changes and environmental insults. This
adaptation and maintenance of normal signaling levels under
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These observations suggest two possibilities to explain the
mechanisms that can yield robustness to fluctuations in RA
levels: insensitivity – the physiologically relevant fluctuations
are too small to trigger a significant feedback response; or,
active self-regulation of the RA metabolic network specifically
aimed at overcoming the fluctuations and returning the RA
levels to normal. To discriminate between these two alternative
hypotheses, an unbiased RA network-wide analysis has to
be performed to conclusively compare these scenarios. The
promiscuity of RA network components for each step raises the
possibility of partially overlapping robustness responses across
biological replicates, and would suggest multiple alternative
regulatory and enzymatic scenarios capable of returning the RA
signal to normal developmental levels. The scarcity of studies
performing a network-wide analysis means that the potential
compositional complexity of the RA feedback response has not
been truly explored.
In the present study, we have taken an integrated dynamic
transcriptomics approach to address several unresolved questions
regarding the RA signaling robustness mechanisms during
early embryogenesis. We designed a pulse-chase, transient RA
perturbation protocol to explicitly study the kinetics of the
robustness response using an unbiased, transcriptomic-based
(RNAseq), RA network-wide analysis of the robustness response
to increased versus decreased RA levels. The composition
of the RA metabolic network during gastrulation, and the
individual and network-wide responsiveness to physiological
RA fluctuations were studied. We tested the limits of this
robustness in both directions of RA perturbations and examined
the clutch-to-clutch variations in terms of deviations from
the normal response kinetics. Lastly, we combined the results
from multiple clutches and different experimental techniques
to propose a regulatory scheme that may underlie the
robustness response.

Expression Analysis
For each sample, 5–10 staged embryos were collected and stored
at −80◦ C. RNA purification was performed using the Bio-Rad
Aurum Total RNA Mini Kit (according to the manufacturer’s
instructions). RNA samples were used for cDNA synthesis
using the Bio-Rad iScriptTM Reverse Transcription Supermix
for RT-qPCR kit (according to the manufacturer’s instructions).
Quantitative real-time RT-PCR (qPCR) was performed using
the Bio-Rad CFX384 thermal cycler and the iTaq Universal
SYBR Green Supermix (Bio-Rad). All samples were processed
in triplicate and analyzed as described previously (Livak
and Schmittgen, 2001). All experiments were repeated with
six different embryo batches. qPCR primers used are listed
in Table 1.
For spatial expression analysis of hoxb1 and hoxb4 we
performed whole-mount in situ hybridization as previously
described (Epstein et al., 1997). Probes for in situ hybridization
used were: hoxb1, clone CX19/21 (Godsave et al., 1994) cut with
EcoRI, transcribed with SP6 polymerase; hoxb4, clone E16 (Gont
and De Robertis, personal communication) cut with BamHI,
transcribed with T7 polymerase.

RNASeq Data Analysis
Sequencing was performed at the Thomas Jefferson University
Genomics Core using Illumina HiSeq 4000. Reads were mapped
to the genome using the Xenopus laevis 9.1 genome with STAR
alignment and a modified BLAST and FASTQC in the NGS
pipeline (STAR average mapped length: 142.34). Annotation of
the mapped sequences using verse identified 31,535 genes. Raw
counts were further filtered for non-zero variance across all
samples resulting in 31,440 scaffold IDs. We analyzed the time
series transcriptomic data set for differentially expressed genes
using a two-way ANOVA approach [time points: 0 (wash), 1.5, 3,
4.5 h; treatments: RA, DEAB, control; n = 6 biological replicates].

High Throughput Quantitative Real-Time
RT-PCR

MATERIALS AND METHODS

cDNA samples were directly processed for reverse transcriptase
reaction using SuperScript VILO Master Mix (Thermo Fisher
Scientific, Waltham, MA, United States), followed by real-time
PCR for targeted amplification and detection using the Evagreen
intercalated dye-based approach to detect the PCR-amplified
product. Intron-spanning PCR primers were designed for every
assay using Primer3 and BLAST for 24 genes from Retinoic Acid
metabolism and target pathway (Table 1). The standard BioMark
protocol was used to preamplify cDNA samples for 22 cycles
using TaqMan PreAmp Master Mix as per the manufacturer’s
protocol (Applied Biosystems, Foster City, CA, United States).
qPCR reactions were performed using 96.96 BioMark Dynamic
Arrays (Fluidigm, South San Francisco, CA, United States)
enabling quantitative measurement of multiple mRNAs and
samples under identical reaction conditions. Each run consisted
of 30 amplification cycles (15 s at 95◦ C, 5 s at 70◦ C, 60 s at
60◦ C). Ct values were calculated by the Real-Time PCR Analysis
Software (Fluidigm). Samples were run in triplicate for the 24
genes. The primers in the first pre-amplification group selectively

Embryo Culture
Xenopus laevis frogs were purchased from Xenopus I or NASCO
(Dexter, MI or Fort Atkinson, WI, United States). Experiments
were performed after approval and under the supervision of
the Institutional Animal Care and Use Committee (IACUC) of
the Hebrew University (Ethics approval no. MD-17-15281-3).
Embryos were obtained by in vitro fertilization, incubated in 0.1%
MBSH and staged according to Nieuwkoop and Faber (1967).

Embryo Treatments
All-trans Retinoic acid (RA), Dimethyl sulfoxide (DMSO), and
4-Diethylaminobenzaldehyde (DEAB), were purchased from
Sigma-Aldrich (St. Louis, MO, United States). Stock solutions of
RA, and DEAB, were prepared in DMSO. Two-hour treatments
of 10 nM RA, or 50 µM DEAB, were initiated during late blastula
(st. 9.5) and terminated at early gastrula (st. 10.25) by three
changes of 0.1% MBSH and further incubation in fresh 0.1%
MBSH for the desired time.
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bind for the L homoeologs of the genes. In the second preamplification group, primers were selected for the S homoeologs
only. Third pre-amplification group binds to all 24 genes. In order
to remove the technical variability caused due to L and S gene
homoeologs, Ct value for each gene in a sample was selected as the
median value of the three pre-amplification runs. Relative gene
expression was determined by the 11Ct method. gapdh was used
as a housekeeping gene for normalization of the data.

TABLE 1 | List of PCR primers corresponding to the hox genes and RA metabolic
network for RT-qPCR and HT-qPCR analysis.
Gene

Forward primer

Reverse primer

CACCATCTCCGCCGTCTC

RT-qPCR
rdh10.L

CGTCTCTTTGCCCTGGAGTTT

rdh10.S

TTGCTTGGCCTGTAGAAGAGA

TGCATGGCGAAATAGGAGTAG

sdr16c5.L

TTTGTGGTTCCTTCCCTCTC

GTGCCATCAGTCTCCCTATACC

adhFe1.S

TTGATGCCTTTGTTGCTGTT

CTGCTTTGCCTTTCCCTATT

dhrs3.L

CAGGCGCAAGAAATCCTAAG

CAAAGGCCACGTTACAGGAT

dhrs3.S

TGCAGATGGTATTGTCCCTTC

TCCTTAGCGAGGTGTCGG

rdh14.L

TGCCCGTACACAAAGACAGA

GAGACCAAGGAGGTGGTGAG

aldh1a2.L

TGGAATGTGTGTAGAGTCCAGC TCTTGAGTGGGACCAGGTAGA

aldh1a2.S

TAGAGATGCCCGGAGGAGTG

TTCTAGGTTAGTGCTGGGA
GAAG

aldh1a3.L

GTAAAGGCCCGTCTCAATGC

GAATTCCATTTGCTGCATCC

aldh1a3.S

GGGGAGATCCCTGTAAGGAG

Data Normalization and Annotation
Data analysis on raw gene counts was performed using the
R statistical analysis tool version 3.6.0 on a 64-bit Windows
platform. For the RNA-seq data, the raw gene counts were first
converted into log2-transformed values using the “regularized
log (rlog)” transformation from the DESeq2 package, which
minimizes differences between samples for rows with small
counts (Love et al., 2014). The gene expression data was then
normalized across samples against the experimental variation
and batch effects using the COMBAT method in R using a nonparametric adjustment (Johnson et al., 2007). Following batch
correction, the gene list was filtered for a minimum expression
threshold to remove genes with normalized counts less than 5
across all 72 samples. The expression data for the remaining
genes was normalized using quantile normalization. RNA-Seq
transcript/array probes IDs were transformed to Official Gene
Symbol using merged list from 3 sources: the Xenopus laevis
scaffold-gene mapping, DAVID Bioinformatics Resource 6.8
(Huang et al., 2009) or AnnotationData package “org.Xl.eg.db”
maintained by Bioconductor (Carlson, 2017). The original
scaffold IDs were retained along with the Official Gene Symbols
for cross-reference purposes.

GTTCTGGGGTTTCCCTGACT

cyp26a1.L TCGAGGTTCGGCTTCATC

CGGCACAATTCCACAACA

cyp26a1.S CCGCTTTCTAACGCCACTT

CACAATTCCACCACGAACAC

cyp26c1.L AAACGGGTTCCTTTCTGTGT

GCTTCGATTTACCCTACAC
TCTT

hoxa1.L

CCGCTCACTATATCCACCA
TTC

TGGCAGGAGAACGACAAAC

hoxa1.S

AATTATGAGATGATGGAATGG
TAAA

TGACTGTAAACACCTAGTAA
ATGAGAG

hoxb1.L

TTGCCCCAGTGCCAATGAC

TCCCCCTCCAACAACAAACC

hoxb4.S

CCAAGGATCTGTGCGTCAA

GCAGGATGGAGGCGAACT

hoxd1.S

TTCTTGCGGGGATGTTTTAG

CCGACTGGCATAAAGGAATG

gapdh.S

GCTCCTCTCGCAAAGGTCAT

GGGCCATCCACTGTCTTCTG

slc35b1.L

CGCATTTCCAAACAGGCTCC

CAAGAAGTCCCAGAGCTCGC

ATGTTTGCCTGGAAGATTGC

GAGAGCAGTGAGCGGAGTCT

HT-qPCR
aldh1a2.L

cyp26c1.L AAACGGGTTCCTTTCTGTGT

GCTTCGATTTACCCTACACTCTT

hoxb1.S

CCAACTTCACGACCAAACAA

GTGGCTGCGATCTCTACTCTC

hoxd4.L

TTCCCTACCATCATTCCTTTC

GAGTCATTATTTCCTGCTT
TCTTT

rbp1.L

TGGAAATGCGAGTAGGAGATG

GGGATGGTGGTTTATTGTGTG

rdh13.L

CAAGTGTCTACCTGGCTGTTG

CCCAGAGTTTCCTTGCAGTT

rdh14.L

TGCCCGTACACAAAGACAGA

GAGACCAAGGAGGTGGTGAG

aldh1a3.L

TAAAGCCCTGTCTGTTTCT

CATACTCTCCAAGTTCCCTT

crabp2.L

AGCCACCCAAAGAAGACATAC

CGATAAGAAACGAAAGCAGAAA

crabp2.S

TCAAAGGAGATGGACCCAAGA

ATCAGCAGTCATGGTCAG
GATAAG

cyp26a1.L TCGAGGTTCGGCTTCATC

CGGCACAATTCCACAACA

cyp26a1.S CCGCTTTCTAACGCCACTT

CACAATTCCACCACGAACAC

cyp26c1.S AGCTCTGGTCCTTGAGATGG

AGCCAATGCAGAGTTTCTCC

dhrs3.L

CAGGCGCAAGAAATCCTAAG

CAAAGGCCACGTTACAGGAT

hoxa1.L

CCGCTCACTATATCCACCATTC

TGGCAGGAGAACGACAAAC

hoxa1.S

AATTATGAGATGATGGAATG
GTAAA

TGACTGTAAACACCTAGTAAA
TGAGAG

hoxa3.S

AGCAGGGCAATGGAGTTT

GGAGGGTCCACCAGAATTAG

hoxb4.S

CCAAGGATCTGTGCGTCAA

GCAGGATGGAGGCGAACT

hoxd3.S

CTTCCCAGTCCACAATG
AATAAA

GCTCTTCTCCTCGCAGTTCTC

rdh10.L

CGTCTCTTTGCCCTGGAGTTT

CACCATCTCCGCCGTCTC

rdh10.S

TTGCTTGGCCTGTAGAAGAGA

TGCATGGCGAAATAGGAGTAG

sdr16c5.L

TTTGTGGTTCCTTCCCTCTC

GTGCCATCAGTCTCCCTATACC

stra6.L

CCTGCTTACTTTCCTCCTGTTG

GTGGGTGACATTAAAGATTG
TAGAGA

gapdh.S

GCTCCTCTCGCAAAGGTCAT

GGGCCATCCACTGTCTTCTG
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Differential Gene Expression Analysis
The normalized data was analyzed using an Empirical Bayes
Statistical (eBayes) model that considered the following two
variables and their interactions: (1) Treatment (Control, RA,
DEAB) and (2) Time post-treatment-washout (t = 0, 1.5, 3,
4.5 h) with n = 6 biological replicates. Differentially expressed
genes were identified based on statistically significant effects of
Time, Treatment or an interaction between these two factors.
P-values were adjusted for multiple testing using topTable from
limma (Ritchie et al., 2015) package in R (q ≤ 0.05). The
significance-filtered differential gene expression data was used in
an established Principal Component Analysis (PCA) approach
using the prcomp function implemented in R. The samples
were annotated based on a combination of treatment and time,
yielding 12 distinct sample groups. For each of the selected PCs,
expression of 100 top positively loaded and 100 top negatively
loaded genes was visualized as a heat map.

Dynamic Pattern Analysis and
Comparative Matrix of Pattern Counts
Analysis
First, for each time point, for each of the treatment conditions,
the gene expression data for all six clutches (A,B,C,D,E,F) was
averaged. Within treatment groups, RA, DEAB, Control, the gene
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expression data at time points t = 1.5, 3, 4.5 h was normalized
by subtracting the corresponding “t = 0 h” group. This average
differential gene expression data was then discretized to three
levels (+1, 0, −1) based on a fold-change threshold [±2 (up,
no or down- regulation)]. Within the three treatment groups,
this discretization yielded a dynamic response pattern vector
for each gene, encoded by one of 27 (3 levelsˆ3 time-points)
possible ordered sets. Counts of genes in each treatment group
that follow each of the 27 ∗ 27 (=729) possibilities were compared.
Functional enrichment analysis was performed for geneset in
various dynamic pattern vectors in the Control conditions,
using functions enrichGO and simplify from the R package
“clusterProfiler” (Yu et al., 2012).

Gene correlation and clustering analysis – Gene expression
data was analyzed for both with and without Controlnormalization using Weighted Gene Coexpression Network
Analysis (WGCNA) (Langfelder and Horvath, 2008) to identify
modules of genes with highly correlated differential expression.
We used a soft threshold value of 9 (8 for Control normalized
data) to identify the initial gene coexpression modules, followed
by a dissimilarity threshold of 0.25 to merge the initial
modules into the final set of gene coexpression modules.
Identified modules were further correlated with the traits (batch,
time, treatment).

Robustness Score Calculation and
Principal Curve-Based Trajectory
Analysis

Comparative Matrix of Pattern Counts
Analysis of Retinoic Acid and
4-Diethylaminobenzaldehyde After
Normalizing to Control

RNA-seq expression data of (clutches: A,B,C,D,E,F) and
normalized HT-PCR expression data (clutches: G,H,I,J,K,L) were
independently genewise Z-score transformed. Transformed data
was then combined to result into 144 samples (12 clutches ∗
3 treatments ∗ 4 time points). We further selected two subsets
of genes: (1) “RA metabolism genes” [aldh1a2.L, aldh1a3.L,
crabp2.L, crabp2.S, cyp26a1.L, cyp26a1.S, cyp26c1.L, cyp26c1.S,
dhrs3.L, rbp1.L, rdh10.L, rdh10.S, rdh13.L, rdh14.L, sdr16c5.L,
stra6.L]. This set represents the feedback regulatory mechanism
utilized in response to the RA levels perturbations. (2) “HOX
genes” [hoxa1.L, hoxa1.S, hoxa3.S, hoxb1.S, hoxb4.S, hoxd4.L]
representing the phenotypic outcome from the treatment. For
each gene set, the PCA scores for the combined data was first
calculated using R function prcomp and then the scores from
the first three principal components (PC1, PC2, and PC3) are
used to learn a 3-dimensional principal curve using the function
principal_curve from R package princurve. Two sets of points
are specified for the “start” parameter for this function, which
determines the origin and direction of the curve: (1) The centroid
of the 0 h-Control samples from all twelve clutches, and (2)
centroid of all the remaining 132 samples. For each geneset (RA
metabolism genes and HOX genes), for each clutch (A-L), for
each treatment (RA or DEAB), a “net absolute expression shift”
can be calculated as the sum of distances along the principal
curve, of the treatment samples from the corresponding control
samples:

First, for each time point, for each of the treatment conditions,
the gene expression data for all six clutches (A,B,C,D,E,F) was
averaged. Within treatment groups, RA and DEAB, the gene
expression data were normalized to Control at each time point
by subtracting the expression of the Control group at the
corresponding time point. This Control-normalized differential
gene expression data for both treatment groups was then
discretized to three levels (+1, 0, −1) based on a foldchange threshold [± log2(1.3) (up, no or downregulation)]. This
discretization yielded a dynamic response pattern vector for each
gene, encoded by one of 81 (3 levelsˆ4 time-points) possible
ordered sets. Subsequently, RA and DEAB groups were compared
to count the number of genes corresponding to each of the 81 ∗
81 (=6561) possibilities; to create an 81 × 81 matrix representing
the comparative dynamic response pattern counts (COMPACT)
(Kuttippurathu et al., 2016). For a given COMPACT matrix
of comparative conditions RA (vs. Control) and DEAB (vs.
Control), the element at the ith row and jth column of the matrix
contains the number of genes that show an “i”th pattern in
DEAB and “j”th pattern in RA. For a coarse-grained version of
the detailed 81×81 COMPACT, pattern-vector counts for each
treatment group were further aggregated based on the first timepoint, yielding 9 groups of pattern vectors per treatment group.
The pair of treatment groups (RA and DEAB) was then compared
to count the number of genes corresponding to each of the 9 ∗ 9
(=81) possibilities.

RA(t)

s.hoxclRA

=

X
t

abs(

λ.hoxcl

Control(t)

− λ.hoxcl

max(λ.hox)

)

RA(t)

where, λ.hoxcl is the arc-distance from the beginning of the
curve, for the “RA treatment samples” at time point “t,” for clutch
“cl” for the principal curve learned for the geneset “Hox genes”
(Returned as the parameter “lambda” from the principal curve
function). The expression shift calculation allows ranking and
sorting clutches based on “HOX shift” (s.hoxtreatment
) and “RA
cl
Network shift” (s.metabolismtreatment
).
A
lower
HOX
shift for a
cl
clutch for a treatment indicates that the clutch is more robust
to that particular treatment/perturbation. Furthermore, clutches
were mapped onto the conceptual map across the spectrum of
“HOX shift” and “RA Network shift” divided into hypothetical

Retinoic Acid Network Map and
Visualization
A schematic representation for the position and function of
genes involved in RA biosynthesis, metabolism, translocation,
and transcription during gastrula stages was derived by data
mining. The gastrula expression of each gene was confirmed by
qPCR. For each time point, for each treatment, expression value
for each gene was mapped to the corresponding label in the
schematics using a color scale.
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RA manipulation (Figures 1B,C). The second component (PC2)
separated the sample groups at intermediate time points (t = 1.5
and t = 3 h) from those at t = 0 and 4.5 h, indicating a transient
differential expression shift as the next most dominant pattern
in the data (Figures 1B,C). These results show that overall,
the dynamic transcriptome is maintained along the normal
developmental trajectory despite the perturbations to RA levels.
The effects of RA and DEAB on the transcriptome were
not readily apparent in the first seven principal components.
PC8 showed some separation of the DEAB group from the RA
and Control groups (Supplementary Figures 1A,C), whereas
PC10 showed some separation of the RA treatment group from
Control and DEAB treatments (Supplementary Figures 1B,D).
The top-ranked genes along PC8 and PC10 showed distinct
dynamic expression patterns across the treatments, whereas topranked genes along PC1 and PC2 largely corresponded to incommon dynamic changes over time (Figure 1B; Supplementary
Figure 1C). These observations suggest that RA signaling
robustness dampens the gene expression changes otherwise
induced by abnormal RA levels in agreement with a robust system
that functions to limit the gene expression changes in the majority
of the transcriptome.

quadrants of Effective or Ineffective regulation, or Efficient or
Inefficient regulation.

RESULTS
Transient Physiological Perturbations to
Study Retinoic Acid Signaling
Robustness
To directly investigate the robustness of RA signaling, we
designed a pulse-chase RA manipulation protocol to transiently
perturb this signaling pathway beyond its normal, and
developmentally changing levels, and study the feedback
regulatory changes involved in restoring its normal signaling
levels (Figure 1A). The network-wide changes of the transient
RA disturbances and restoration of normal signaling levels
were monitored by kinetic transcriptomic analysis (RNAseq).
Parameters such as developmental stages and timing between
samples were empirically optimized (not shown). This
experimental approach expands on reports describing RAdriven regulation of its own metabolic and signaling network
components. To reduce RA levels below the normal content
in early embryos, we partially inhibited the oxidation of RAL
to RA with the RALDH inhibitor 4-diethylaminobenzaldehyde
(DEAB) (Shabtai et al., 2016). We chose 50 µM DEAB for RA
reduction as our enzymatic (IC50 and Ki ) and phenotypic studies
supported a partial inhibition (Shabtai et al., 2016, 2017). To
increase RA levels for robustness analysis in a physiologically
relevant manipulation, we treated embryos with 10 nM all-trans
RA which is below the reported physiological RA content of
early/mid gastrula Xenopus laevis embryos (about 100–150 nM
all-trans RA) (Durston et al., 1989; Schuh et al., 1993; Chen et al.,
1994; Creech Kraft et al., 1994, 1995; Kraft et al., 1994, 1995).
Transient pharmacological RA manipulations of early
Xenopus embryos were performed by treating with RA or DEAB
for 2 h from late blastula (st. 9.5; t = −2 h) to early gastrula (st.
10.25; t = 0 h), washed, and samples collected every 1.5 h (t = 1.5,
3, 4.5 h) after treatment termination (Figure 1A). For each
biological repeat, all treatments, controls, and time points were
collected from a single clutch (eggs) of a single female. Treatment
efficiency and quality of the RNA samples was first monitored
by quantitative RT-PCR (qPCR) for changes in cyp26a1.L,
hoxa1.L, and hoxb4.S gene expression as internal readouts of the
changes in RA signal levels. Only those biological repeats where
both treatments exhibited the expected upregulation (RA) or
downregulation (DEAB) of gene expression were selected for
RNAseq analysis.
Principal Component Analysis (PCA) of the gene expression
variation showed separation along the first principal component
(PC1) which corresponds to transcriptomic changes of the
normal progression through gastrulation (Figures 1B,C). RAmanipulated samples clustered with the control samples of the
same developmental stage suggesting a robust maintenance of
transcriptome composition. Normal transcriptomic changes as
a result of progression through embryogenesis appear to be the
dominant variable distinguishing the samples irrespective of the
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Retinoic Acid Signaling Exhibits Efficient
Robustness
Further support for the robustness of RA signaling was obtained
by phenotypic and molecular analysis of embryos treated for
RA knockdown. Xenopus embryos treated with the RALDH
inhibitor, DEAB (50 µM), or overexpressing CYP26A1 to render
RA inactive (Hollemann et al., 1998; Yelin et al., 2005; Topletz
et al., 2015; Shabtai et al., 2017). These embryos developed mild
microcephaly and slight axial shortening as previously described
(Shabtai et al., 2017), which are unexpectedly mild defects for
such an important signaling pathway (Figures 2A–C,E). The
induction of severe phenotypes by RA loss-of-function required
the combined RA knockdown with both treatments targeting
the metabolism at different steps (Figures 2D,E) supporting the
observed robustness of RA signaling. Analysis of changes in
hoxa1 or dhrs3 expression supported the conclusion that the
individual RA-knockdown treatments result in moderate gene
expression changes (Figures 2F–H), and severe gene expression
changes are observed when both treatments were combined
(Figures 2F–H). These results further support the notion that RA
robustness needs to be overcome to elicit strong gene expression
and phenotypic changes.
To begin exploring the limits of the robustness response to
increased RA levels we treated embryos with increasing RA
concentrations in the physiological range and above (1 nM –
1 µM). Treated embryos were analyzed for morphological
malformations, microcephaly, trunk shortening, and loss of
tail, by early tailbud stages (st. 32–33) and revealed that the
RA treatments induced developmental malformations whose
severity increases in correlation to the amount of RA added
(Figures 3A,B). While exposure to 10 nM RA resulted in
very mild malformations involving mainly the anterior head
(forebrain) region, 50 nM RA induced a clear and relatively
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FIGURE 1 | Efficient RA signaling robustness following transient physiological manipulation of RA levels. (A) Schematic depiction of the experimental design to
directly challenge and study the robustness of RA signaling during embryogenesis. Timing and developmental stages are shown. (B) Principal Components 1 and 2
(PC1, PC2) of all six biological replicates studied by time series RNAseq. (C) Heatmap of gene expression of the top-100 positive and top-100 negative loadings
corresponding to PC1 and PC2. A subset of the genes is highlighted based on the relevance to early developmental processes.

(lower) RA concentration. As determined by qPCR for hoxb1
(Figure 3C), for both genes we observed the expected RA
concentration-dependent in situ hybridization signal intensity
increase (Supplementary Figure 2). In parallel, we observed
a widening of the expression domain of both genes along the
anterior-posterior axis (Supplementary Figures 2A–C,E–G).
Further support for the robustness of RA signaling came from
the in-depth analysis of the kinetic transcriptomic changes. We
analyzed the averaged data for all biological repeats using an
unbiased dynamic pattern analysis approach along all possible
discretized patterns of gene expression (Kuttippurathu et al.,
2016). Following normalization to t = 0 h, up- or downregulated genes beyond the significance threshold at each time
point were scored as either +1 or −1, respectively, or 0 for
no significant change (Supplementary Figure 3A). Such an
exhaustive approach allows us to enumerate the dominant as
well as subtle patterns in the data overcoming limitations of
conventional cluster analysis that could miss or mask the smaller
groups of genes with distinct expression profiles over time.

strong phenotype, and 100 nM RA resulted in severe defects, both
affecting the head (severe microcephaly) and trunk (anteriorposterior axis) regions (Figures 3A,B). In similarly treated
embryos, we analyzed the expression changes of genes encoding
RA metabolic enzymes and RA targets (hox genes) during
early (st. 10.25) and late gastrula (st.12) (Nieuwkoop and
Faber, 1967). Genes positively regulated by RA at both stages,
hoxb1, cyp26a1, and dhrs3 exhibited dose-dependent responses
(Figures 3C–E). The genes, aldh1a2 and rdh10, were downregulated by most RA doses (Figures 3F,H), while aldh1a3
(raldh3) was upregulated at early gastrula and was repressed late
gastrula (Figure 3G). Importantly, in many instances, treatments
above 10 nM RA resulted in stronger changes in gene expression
or the transition to more severe malformations suggesting an
upper limit to the robustness response. We also studied the
effects of graded increase in RA levels on the spatial expression
patterns of hoxb1 and hoxb4 (Supplementary Figure 2). We
performed a visual estimation of the expression level changes
compared to control embryos, or compared to the previous
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FIGURE 2 | Phenotypic and molecular robustness of the retinoic acid metabolic pathway. Retinoic acid levels were reduced in Xenopus laevis embryos by inhibition
of the RALDH activity with DEAB or by CYP26A1 overexpression to render retinoic acid inactive. (A) Control embryo at st. 27. (B) Embryo injected with capped RNA
(0.8 ng) encoding the CYP26A1 enzyme. (C) Embryo treated with DEAB (50 µM) from st. 8.5 until st. 27. (D) Embryo treated with DEAB and injected with cyp26a1
mRNA. To exemplify the induced developmental malformations, lines depicting the size of the head domain (blue) and the trunk (red) were drawn on the control
embryo (A) and then copied unto the treated embryos (B–D). (E) Distribution of the developmental defect severity induced by the retinoic acid manipulations.
Embryos were scored for the induction of moderate (B,C) or severe (D) phenotypes, or normal looking. (F–H) Gene expression changes as a result of retinoic acid
manipulation. qPCR analysis of hoxa1.L (F), hoxa1.S (G), and dhrs3.L (H) relative expression levels as a result of the individual or combined retinoic acid
manipulations. Statistical significance (Student’s t-test) was calculated compared to the combined treatment group. *p < 0.05; **p < 0.01; ****p < 0.0001; ns, not
significant.

not vary substantially (Supplementary Figure 3), consistent with
the observed robustness.

Expression of a total of 4,693 genes significantly changed
more than two-fold over time (compared to t0; multiple
testing corrected q-value < 0.05), and surprisingly they only
grouped in 10 out of the possible 27 (3∗ 3∗ 3) dynamic patterns
for any of the experimental groups (RA, DEAB, Control)
(Supplementary Figure 3A). Only 5 patterns included 100
or more genes in any experimental group, corresponding to
up- or down-regulation at later time points (3 and 4.5 h) in
agreement with a return to normal expression levels after the
initial RA-dependent disruption (Supplementary Figure 3A).
There were no significant differences in the gene counts
between RA or DEAB and control groups (two-tailed Z
test, p > 0.05). Gene Ontology enrichment of the control
group highlighted development, cell cycle, morphogenesis, RA
biosynthesis, gastrulation, and others (Supplementary Figure 3B
and Supplementary Table 1). At this level of analysis, we could
not observe distinctive dynamic gene expression patterns that
occur only in response to the RA or DEAB treatments. Venn
diagram analysis revealed limited (about 20–30%) treatmentspecific gene expression changes that do not overlap with control
samples for each pattern. For instance, in the subset of genes that
showed late downregulation (pattern 0, 0, −1; Supplementary
Figure 3C) only 216 genes in DEAB or 187 genes in RA, did
not overlap with the control sample (1,175 genes) showing that
only about 18% of the genes changed as a result of the treatments
beyond the normal developmental changes. The expression
changes relative to the end of the RA perturbation (t = 0 h) did
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Retinoic Acid Network-Wide Responses
to Restore Normal Signaling Levels
We exhaustively compared the RA and DEAB treatments
adapting our unbiased COMPACT approach for analyzing
time-series differential transcriptomic profiles across multiple
experimental conditions (Kuttippurathu et al., 2016). For
statistically significant changing genes within each treatment
group (two-way ANOVA; q < 0.05), we constructed discrete
patterns based on differential gene expression between treatment
(RA or DEAB) and control at each time point (81 theoretically
possible patterns). Also here, only 32 distinct patterns with at
least one gene in either comparison were observed (Figure 4A).
The effect threshold, 1.3-fold average difference, was chosen
lower than 2-fold, as the differential expression analysis revealed
that the RA/DEAB perturbations were leading to a smaller
magnitude of changes at each time point, as compared to
the larger changes occurring normally over time (Figure 1B
and Supplementary Figure 3), providing additional evidence
of the robustness. Intersecting the two distributions yielded
a matrix where each element corresponds to a distinct pair
of patterns corresponding to the gene-specific response to
increased (RA vs. control) and decreased (DEAB vs. control) RA
signaling (Figure 4B).
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FIGURE 3 | Transient physiological manipulation of RA levels for robustness analysis. (A) Embryos were treated with increasing concentrations of all-trans RA from 1
nM to 1 µM. Treatments were initiated at st. 8.5 and RNA samples were collected at tailbud stages (st. 32–33) for phenotypic analysis. To exemplify the induced
developmental malformations, lines depicting the size of the head domain (blue), the trunk (red), and the tail (purple), were drawn on the control embryo (-RA) and
then copied unto the treated embryos (10–1,000 nM). (B) Distribution of the severity of the developmental defects induced by the retinoic acid manipulations.
Treated embryos were scored for the induction of moderate (as in 25 or 50 nM) or severe phenotypes (as in 100 or 1,000 nM), or normal looking (as in -RA). (C–H)
RA treated embryos were collected at early (st. 10.25) and late (st. 12) gastrula for analysis of the changes in expression level. The response of RA metabolic and
target genes was studied by qPCR. (C) hoxb1 (D) cyp26a1 (E) dhrs3 (F) aldh1a2 (G) aldh1a3 (H) rdh10. Statistical significance (Student’s t-test) was calculated
compared to the control group. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant.

Surprisingly, the COMPACT matrix (Figure 4B and
Supplementary Data 1) shows that the majority of the genes
exhibited sensitivity to only one direction of the RA perturbation.
A total of 193 genes only responded to the addition of RA (middle
row), whereas 224 genes were only responsive to RA knockdown
(middle column). Of the genes responsive to both RA and DEAB
perturbations, 88 genes responded in the same direction to both
treatments (quadrants a and d; Figure 4B). Only a set of 48 genes
showed opposite transcriptional outcomes to RA increase versus
RA decrease (quadrants b and c; Figure 4B). Importantly, the set
of genes that showed upregulation by exogenous RA addition
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and downregulation by DEAB (quadrant b; Figure 4B) was
enriched for genes involved in RA metabolism (Figures 4B,C).
Analysis of the RA signaling robustness revealed a complex,
network-wide transcriptional response aimed at altering enzyme
levels to redirect the metabolism of RA toward restoration
of normal signaling levels. To better understand the networkwide response we proceeded to determine the components of
the RA network expressed during early gastrula to specifically
analyze them from the transcriptomic data. The RA network
composition during early/mid gastrula was determined by data
mining starting from a list of 27 possible RA metabolic and
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FIGURE 4 | Comparative pattern analysis to uncover genes responding to opposing RA manipulations. (A) Genes were grouped into discretized expression patterns
based on up-regulation (yellow), down-regulation (blue), or no change (gray) compared to the control sample at the same time point. The numbers below the
patterns indicate the number of genes that show the corresponding expression pattern in RA vs. control or DEAB vs. control. Only 32 out of 81 theoretically possible
(four time points, 3*3*3*3 = 81) dynamic patterns were exhibited by at least one gene and are included in the figure. (B) COMPACT matrix comparing gene
expression changes due to RA and DEAB relative to control. The subset of 32 × 32 patterns with non-zero number of genes in either perturbation group are shown.
The gene counts were grouped within related patterns based on the time of initial up- or down-regulation. Supplementary Data 1 contains a version of the
COMPACT matrix shown with the gene identifiers corresponding to the counts. The different quadrants are labeled a to d. (C) Dynamic expression patterns of genes
showing opposite changes in response to RA and DEAB treatments (quadrant b).

network genes (Figure 5B). Expression changes in response to
RA treatment are larger that to RA knockdown (DEAB). Also
importantly, the t = 0 h time point summarizes the response
during early gastrula of the RA network genes to increased
and decreased RA signaling levels (Figure 5B black box). These
results clearly show a network-wide response as part of the
robustness of the pathway.
We mapped the expression changes in response to RA
perturbation (Figures 4B,C) to the RA metabolic network
(Figure 5A). Notably, based on their reported preferential
enzymatic activity, not all genes exhibited their expected
gene expression change (Figures 5B–D). For instance,
following transient RA addition, genes encoding enzymes
with a preferential retinaldehyde reductase activity (rdh14 and
adhFe1) undergo at later time points downregulation, and not
the expected upregulation (Figure 5C). As an independent
validation, we analyzed the differential expression time series

signaling network components. For 12 of the 27 genes, we
found transcriptomic support in our data or additional RNAseq
data sets (Xenbase.org) (Yanai et al., 2011; Savova et al., 2017;
Karimi et al., 2018). All putative RA network components were
validated by determining their temporal expression pattern by
qPCR, analyzing both homeologs (L and S genes) when present
in the X. laevis genome (Supplementary Figure 4). The basic RA
metabolic network analyzed includes during early/mid gastrula
12 genes out of which 4 are singletons and 8 are present as L or S
homeologs (Figure 5A; Session et al., 2016).
We analyzed the averaged expression change from all the
replicates of the hox genes to monitor the change in RA signal
intensity (Figure 5B) and the RA metabolic network genes to
begin understanding the robustness response (Figure 5B). From
this quantitative estimation of the gene expression changes we
can observe the robustness of RA signaling as the expression
shift decreases with recovery time for the hox targets and the RA
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FIGURE 5 | Network-wide response to transient RA manipulations. (A) RA metabolic network components and RA target genes analyzed during early/mid gastrula.
The homeolog (L&S) or singleton status of the gene(s) in the genome is denoted outside the box with the gene name. The gene names shown include a .L suffix to
mark in cases where only one of the homeologs changed significantly in the RNAseq and HT-qPCR data. (B) Analysis of the expression change during the recovery
period following the transient increase (RA) and decrease (DEAB) in RA levels. The hox gene and the RA metabolic network component changes were averaged from
the RNAseq and HT-qPCR analyses. The black frame around the t = 0 h time point denotes the network-wide response at the end of the treatment. *p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001; not labeled, not significant. (C,D) Mapping the differential expression data onto the RA network shown in panel (A) to
highlight the differences in regulation of biosynthesis versus degradation of RA signal between RA and DEAB treatment groups.

Frontiers in Cell and Developmental Biology | www.frontiersin.org

11

October 2021 | Volume 9 | Article 747969

Parihar et al.

Embryonic Retinoic Acid Signaling Robustness

studied by qPCR for both homeologs (Figures 6A–F). The results
show that genes encoding RA production limiting enzymes
(DHRS3) or enzymes promoting RA degradation (CYP26A1)
exhibit a robust, dose-dependent response to increased RA
similar to well-characterized RA target genes such as hoxa1
(Figures 6A–C). In contrast, as a result of RA reduction, no
clear response trend could be observed, but by 25 µM DEAB,
expression of both, dhrs3 and cyp26a1 decreased by about 30%
similar to hoxa1 (Figures 6A–C). For genes encoding enzymes
active in RA production, the situation is more complex. rdh10
exhibited a dose-dependent reduction trend with increasing RA
concentrations (Figure 6D). In contrast, reducing RA levels
did not uncover a clear regulatory response. During mid
gastrula, aldh1a2 exhibited a mixed response to different levels
of increased or decreased RA (Figure 6E). Also, aldh1a3 is downregulated as a result of RA addition but no clear trend is observed
and exhibits a mixed response to RA reduction (Figure 6F).
These results recapitulate in more detail the basic observations
of the COMPACT (Figure 4B) and the pattern response analysis
(Supplementary Figure 3A) where many of the genes respond to
only one direction of RA perturbation.
The PCA analysis revealed that all samples (RA, DEAB,
and control) from the same biological repeat (clutch) tended
to cluster together, but the different clutches separated slightly
from each other suggesting some clutch-dependent heterogeneity
in gene expression (Figure 1B; Supplementary Figure 6). For
this reason, we analyzed the transcriptional changes in the
RA metabolic network within each clutch from the RNAseq
data (labeled A-F). In parallel, we generated an additional set
of biological replicates (n = 6) to further study the dynamic
expression changes in RA metabolic network genes using
high-throughput real-time PCR (HT-qPCR; Fluidigm Biomark;
Supplementary Figure 7) to validate the RNAseq results. These
six additional biological repeats (labeled G-L) were treated with
RA or DEAB following the same experimental design used for the
RNAseq study (Figure 1A). We observed a similar heterogeneity
between clutches analyzed by HT-qPCR to the clutch-to-clutch
variation in the RNAseq data (Supplementary Figures 6, 7).
We ordered the 12 clutches according to the earliest time
point at which hoxa1 returned to control levels (Figure 6G
and Supplementary Figure 8) intermingling clutches of both
studies. We observed high variability in the response to the
RA manipulation among the individual clutches. Interestingly,
clutches with significant hoxa1 upregulation following RA
addition showed limited downregulation in response to RA
biosynthesis inhibition (clutches C, L, J, K, H, I in Figure 6G).
Clutches E, D, F, G, A, B (Figure 6G) showed the opposite
response, i.e., robust hoxa1 change following RA knockdown,
while RA increase induced a milder response. The RA
suppressors, e.g., cyp26a1 and dhrs3, showed significantly altered
expression in clutches with larger deviations in hoxa1 expression
(C, L, J, K, H) and a strong and extended response to the
addition of RA. In contrast, the differential expression of RA
producers (e.g., aldh1a2 and rdh10) after RA manipulation was
relatively mild and did not fully align with the deviation in
hoxa1 expression (Figure 6G). Such a heterogeneous correlation
between the extent of feedback regulation and clutch-to-clutch

data using another unbiased approach, Weighted Gene
Correlation Network Analysis (WGCNA) (Langfelder and
Horvath, 2008). A WGCNA gene expression module with the
highest correlation with treatment contained a similar gene set as
shown in Figure 4C, supporting the COMPACT analysis (green
module, Supplementary Table 2; Supplementary Data 2). Taken
together, our results support a network-wide mechanism to
maintain RA signaling levels to counter the effects of external
perturbations and prevent teratogenic effects by a transcriptional
feedback control system.
To cross-validate the observed kinetics of the RA robustness
response, we performed the pulse-chase RA perturbations in
other independent clutches of embryos (Figure 1A) and analyzed
the expression changes by qPCR (Supplementary Figure 5).
In RA-treated embryos, the two RA-regulated genes, hoxb1
and hoxb4, were upregulated at the time of treatment washing
(t = 0 h) (Supplementary Figure 5A), and 2 h into the
recovery (t2), both RA target genes were back to control
expression levels. We studied the expression of dhrs3, which
preferentially reduces RAL to ROL to attenuate RA biosynthesis
(Feng et al., 2010), cyp26a1, which targets RA for degradation,
and aldh1a2 that produces RA from RAL (Shabtai et al.,
2016), to begin understanding the RA robustness response. Both
negative RA regulators of RA biosynthesis, dhrs3, and cyp26a1
were upregulated at t = 0 by increased RA and return to
normal expression levels after a 4-h recovery (Supplementary
Figure 5B). As expected, aldh1a2 exhibited an RA-promoted
weak downregulation at t = 0, returning to normal levels
after 4 h (Supplementary Figure 5B). These results exemplify
how the gene expression levels of RA metabolic enzymes are
regulated to achieve normal RA levels as part of the robustness
response. A complementary study performed by inhibiting
RA biosynthesis with DEAB (Supplementary Figures 5C,D)
revealed that all genes studied exhibited fluctuations during
the recovery period. The genes hoxd1 and hoxb1 reached
almost normal levels at an earlier stage than the genes
encoding RA metabolic components, again showing a concerted,
network-wide, response of the RA metabolic network to restore
normal developmental RA levels and hox gene expression
(Supplementary Figure 5C). Genes encoding anabolic enzymes,
e.g., aldh1a2, were upregulated, and catabolic components,
e.g., cyp26a1, were downregulated (Supplementary Figure 5D),
consistent with a network-wide response model of adjusting the
pathway component expression (and activity) to restore normal
RA signaling levels.

Direction-Dependent Uneven Retinoic
Acid Robustness Response Efficiency
To better characterize the gene responses observed in the
RNAseq study to RA manipulation, we performed a detailed
titration of RA levels and determined the response of the
main RA network genes. Multiple embryo clutches (n = 5)
were exposed to increasing concentrations of RA (1, 10, 100,
and 1,000 nM) or several concentrations of DEAB (1, 5, 10,
25, and 50 µM) to induce a gradual reduction in RA levels
during mid gastrula (st. 11). Gene expression changes were

Frontiers in Cell and Developmental Biology | www.frontiersin.org

12

October 2021 | Volume 9 | Article 747969

Parihar et al.

Embryonic Retinoic Acid Signaling Robustness

FIGURE 6 | RA responsiveness and differential expression dynamics of select RA network genes and targets in different clutches. (A–F) Embryos were treated at
midblastula (st.8.5) with increasing concentrations of RA (1–1,000 nM) or DEAB 1–50 µM) to generate a gradient of RA responses. At mid gastrula (st. 11) the
changes in RA network genes was determined by qPCR. (A) hoxa1.L, hoxa1.S; (B) dhrs3.L, dhrs3.S; (C) cyp26a1.L, cyp26a1.S; (D) rdh10.L, rdh10.S;
(E) aldh1a2.L, aldh1a2.S; (F) aldh1a3.L, aldh1a3.S. (G) Dynamic expression patterns of multiple RA network genes across the different clutches. The data was
combined from RNAseq (clutches A-F) and HT-qPCR (clutches G-L). The clutches are ordered left to right based on the earliest time at which hoxa1 expression
returned to the baseline levels.

variation in hoxa1 expression was observed across the RA
metabolic network (Supplementary Figure 8).

of each clutch in an integrated manner based on the expression
shift kinetics of the hox genes and to analyze the feedback
response of the RA metabolic network genes. We implemented a
trajectory-based approach in which the samples of all biological
repeats (clutches) at all time points were projected onto the
first three principal components based on the expression of hox
genes (hoxa1, hoxa3, hoxb1, hoxb4, hoxd4) or the RA metabolic
network genes (Figure 7A and Supplementary Figure 9A).
A principal curve was fit to the projected data, representing

Uneven Robustness in Response to
Increased Versus Decreased Retinoic
Acid Signaling
To better understand the different clutch responses to RA
manipulation, we sought to quantitatively rank the robustness
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FIGURE 7 | Trajectory analysis to compare the extent of individual clutch robustness based on hox expression. (A) 3-dimensional principal curve for the hox genes,
showing projections of the sample points on the curve for (A, top) RA and (A, bottom) DEAB treatments. Principal curves for clutches C, J, and E are shown. The
black star indicates the beginning of the curve for the distance measurement along the trajectory. Ranking of clutches is based on the net (absolute) normalized
distance of treatment samples from the corresponding control sample for each time point. (B) Normalized expression shift profile calculated from the principal curve
as the arc distance between the treatment and the corresponding control. Clutches are rank-ordered from lowest to highest net expression shift for hox genes in the
RA group. Clutches A-F data from RNA-seq, clutches G-L data from HT-qPCR. (C) Distribution of clutches based on the trajectory determined robustness to RA and
DEAB treatments relative to each other based on hox expression. The letters indicate the distinct clutches. (D) Heat map representation of gene expression changes
of five additional clutches transiently treated with RA or DEAB. Samples were analyzed at the end of the pulse (t0) and 2 h in the chase (t2). Asterisks denote
clutches with abnormal responses.

the trajectory in which the system evolves over time for all
clutches combined. Each clutch was visualized separately along
the principal trajectory, allowing us to compare the temporal
evolution of deviations between RA manipulations and controls
(Figure 7A and Supplementary Figure 9A). As a multi-gene
measure of the robustness of each clutch, the net absolute distance
between samples and controls was computed at all time points
along the principal curve. The distance between treatments
and controls decreased over time, with significant differences
between clutches in the time taken to close the gap (Figure 7B
and Supplementary Figure 9B). The wide range of clutch-toclutch robustness variability assessed by analysis of multiple hox
genes showed that clutches with low robustness to increased RA
showed larger distances between samples and controls at any
time point (Figure 7A, clutch C), compared to robust clutches
with decreasing distances (Figure 7A, clutch E). In contrast,
DEAB treatment resulted in an opposite robustness pattern
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(Figure 7A), with clutch C showing the least deviation and clutch
E the widest deviation (Figure 7A bottom row and Figure 6B).
Clutch J exhibited intermediate robustness responses to both RA
manipulations (Figures 7A,B). The anti-correlated pattern of RA
robustness suggests an uneven tradeoff in the gastrula embryo
to counter changes in RA levels (Figure 7C). The hox responses
to altered RA levels revealed that all biological repeats aligned
along a negative-slope diagonal and covered the whole range of
responses (Figure 7C). This result suggested the establishment
of an RA robustness gradient among the clutches and a trade-off
in the intrinsic capacity to counteract increased or reduced RA
levels, i.e., uneven robustness.
A similar analysis of the genes encoding RA network
components showed a scattered pattern among the biological
repeats with no clear trend, but a characteristic pattern of
reduced deviation over time in several clutches (Supplementary
Figures 9A,B). There was no significant correlation in the
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FIGURE 8 | Differential robustness to direction of RA change is related to the effectiveness of feedback regulatory action. (A,B) Comparative distribution of clutches
based on the trajectory determined robustness to RA (A) and DEAB (B). The change of the hox genes as a function of the change in the RA network genes is
plotted for each RA manipulation. The letters indicate the distinct clutches. (C) Schematic diagram of the robustness efficiency-efficacy matrix in which different
quadrants indicate the relative level of feedback observed and robustness achieved. (D,E) Mapping the differential expression data of clutches A, E, and F onto the
RA network shown in Figure 5A to highlight the heterogeneity of differential regulation of RA network components for clutches closely situated in the robustness
efficiency matrix (A,B).

net shift in feedback regulatory action between RA addition
versus reduction (Supplementary Figure 9C). Importantly, the
scattered clutch distribution depended on the direction of the
RA manipulation. The range of clutch distribution for DEAB
treatment suggests a response to very small RA reductions and
an upper response limit (Supplementary Figure 9C). In contrast,
the clutch distribution in response to RA addition suggests that
the response requires a minimal threshold change to be activated
and it also exhibits an upper threshold. These observations
suggest a high sensitivity to any amount of RA reduction but a
lower sensitivity to small increases in RA levels.
Independent validation of these observations was performed
by transiently treating multiple additional embryo clutches (n = 5;
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M-Q) to disturb RA levels (RA or DEAB). Individual gene
responses were analyzed by qPCR at the end of the treatment
(t0) and 2 h into the recovery from the treatment (t2). Following
transient RA treatment, the expression changes of RA-responsive
genes revealed that in the majority of cases we could observe the
expected initial up-regulation and the subsequent relative downregulation (Figure 7D). As we observed previously in the RNAseq
and HT-qPCR individual clutch analysis where some clutches (L,
H, G) exhibited apparently reversed responses (Figure 6G and
Supplementary Figure 8), also in this case, clutch Q exhibited
a relative up-regulation during the recovery period (Figure 7D).
Following the transient reduction of RA levels (DEAB), we also
observed clutches (N and P) that did not exhibit the characteristic

15

October 2021 | Volume 9 | Article 747969

Parihar et al.

Embryonic Retinoic Acid Signaling Robustness

expression of aldh1a2 and aldh1a3 to increase RA production
(Figures 8B,E).
The observations of the uneven and only partially overlapping
transcriptomic changes between clutches led us to begin
exploring the alternative RA-regulated expression shifts of
individual network components to achieve signaling robustness
(Figure 9). Based on the analysis of clutch-specific responses,
we propose a regulatory scheme to help explain how different
alternative strategies of changes to the RA network activity can
lead to similar robustness levels. This decision tree exemplifies
how each clutch follows a decision trajectory based on the
direction of RA fluctuation and clutch-specific composition of
RA network variants (Figure 9). In this decision tree scheme,
RA network-wide adjustments in response to increase versus
decrease in RA follow distinct non-overlapping trajectories. From
our results on the gradient of clutch-wise robustness (Figure 6G),
it follows that each clutch is likely optimized to follow a
trajectory in the decision tree with a trade-off for following
other trajectories, such that high robustness to one direction of
RA fluctuation may be achieved at the cost of low robustness
to opposite direction of perturbation in RA levels, i.e., uneven
robustness. In addition, clutches could also be optimized to
follow multiple trajectories with reduced robustness capacity in
each scenario, yielding moderate robustness to either direction
of RA fluctuation. Taken together, these results provide strong
evidence that the early embryo is capable of robust maintenance
of RA levels by mounting a range of network-wide feedback
regulatory responses, which are constrained by an apparent
trade-off that unevenly limits robustness for one of the directions
of RA fluctuation.

up-regulation during the recovery period (Figure 7D), but rather
exhibited a relative down-regulation like clutch K (Figure 6G
and Supplementary Figure 8). Importantly, the same clutches
with abnormal responses (Q, N, P), exhibited normal responses
to the complementary RA manipulation supporting the uneven
response to increased versus decreased RA levels.

Robustness Variability Impacts the
Efficiency-Efficacy of the Response to
Retinoic Acid Manipulation
Plotting the robustness response outcome (trajectory analysis) of
the RA target genes (hox genes) (Figure 6A) as a function of
the change in the RA metabolic network required to achieve the
recovery from the RA manipulation (Supplementary Figure 9A)
can provide insights on the effort invested by each clutch
to achieve its own specific level of RA signaling robustness
(Figures 8A,B). The response to increased RA levels showed
some correlation between the RA network and hox shifts
(Figure 8A). Interestingly, increased RA prompted a strong
feedback response in 9 out of 12 of the clutches, but only half
of them achieved a high robustness outcome (Figure 8A). Also,
two clutches exhibited a highly efficient robustness response with
a mild feedback response (Figure 8A). In agreement with the
proposed uneven robustness response, for reduced RA levels, the
outcome (hox shift) as a function of the network shift revealed no
clear correlation (Figure 8B). While we observe hox responses,
i.e., robustness outcomes, throughout most of the range, the
network response exhibits an upper limit (Figure 8B). This clutch
response distribution suggests that although the RA network
exhibits a mild feedback response for all the clutches, this is
sufficient to achieve a sensitive, high robustness to reduced RA
levels in at least 8 out of 12 clutches (Figure 8B; lower left
quadrant). The comparison of the robustness response (hox) and
the effort to achieve it (network response) yielded an efficiencyefficacy matrix, within which clutches whose network response
was low and the hox shift was also minimal were identified as
establishing an efficient robustness response (Figure 8C). At the
other extreme, some clutches exhibited extensive shifts in the RA
network response that were unable to minimize the hox shifts
resulting in an ineffective robustness response (Figure 8C). The
different robustness responses of the clutches analyzed suggested
that for each clutch, the robustness response is the result of a
dynamic adaptation of the components of the network available.
We examined whether neighboring clutches in the efficiencyefficacy matrix (Figure 8C) employ similar strategies for feedback
regulation. Interestingly, we found that the identity of the
differentially regulated genes in the RA metabolic network can
vary between clutches co-localized in the matrix (Figures 8D,E).
For example, in response to increased RA, clutches A, E and
F showed similar differential regulation of dhrs3, aldh1a2, and
cyp26a1, but diverged in stra6, sdr16c5, adhfe1, rdh13, aldh1a3,
and cyp26c1 (Figures 8A,D). Similarly, in response to reduced
RA, clutches A, B, and D showed downregulation of dhrs3 and
cyp26a1, and upregulation of rbp1, suggesting feedback aimed at
reducing enzymes active in RA reduction, and increasing import
of retinol. However, there was high variability in the differential
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DISCUSSION
Robustness of the Retinoic Acid
Signaling Pathway
Signaling pathway robustness is aimed at ensuring signaling
consistency and reliability overcoming changing environmental
conditions or genetic polymorphisms resulting in gene
expression changes or protein activity variation. Commonly,
strong developmental defects by RA manipulation in Xenopus
embryos, and other vertebrate models, are induced by treating
with high RA concentrations in the 1 to 10 µM range (Sive et al.,
1990; Taira et al., 1994). This is in contrast to the estimation
that gastrula stage Xenopus laevis embryos contain RA levels
around the 100–150 nM range (Durston et al., 1989; Schuh et al.,
1993; Chen et al., 1994; Creech Kraft et al., 1994, 1995; Kraft
et al., 1994, 1995). To study the physiological robustness of RA
signaling, we determined that by treating embryos with as little as
10 nM RA (about 10% of the estimated endogenous content) we
could consistently induce measurable, even if less than dramatic,
expression changes in RA-regulated genes. Our results and
other studies have shown that embryo treatments mimicking
physiological fluctuations in RA concentrations exhibit relatively
mild developmental malformations suggesting the activation
of compensatory mechanisms to prevent abnormal gene
expression and developmental malformations (Sive et al., 1990;
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FIGURE 9 | Proposed model of the alternative regulatory schemes to achieve RA robustness. Schematic representation of two alternative scenarios in the decision
tree to achieve robustness. These two scenarios are representative of the multiple permutations possible to achieve similar robustness outcomes. Each clutch
follows a decision trajectory based on the direction of RA fluctuation and clutch-specific composition of RA network variants. In this scheme, uneven robustness
arises when the regulatory feedback response of a clutch is optimized for one scenario over another. Our results revealed such a trade-off over distinct objectives of
counteracting RA increase versus decrease.

efficient robustness to physiological fluctuations. Transcriptomewide analysis of the restoration of normal gene expression
patterns following transient RA manipulation showed that the
transcriptomes of RA-manipulated (increased or decreased) and
control embryos are highly similar (PCA analysis) at each time
point, supporting the robustness of RA signaling to maintain
normal, non-teratogenic, target gene expression levels during
early gastrulation. A deeper analysis revealed only weak, but
measurable, transcriptomic changes that could be attributed to
the RA manipulation. Very mild morphological malformations
could be observed even when significant changes in RA target
genes were observed.
Then, what is the mechanism activated to achieve RA
robustness within the physiological range as observed in our
study? qPCR analysis provided insights on the RA robustness
mechanism showing that target genes exhibited abnormal
expression levels at the end of the manipulation (t = 0), and some
target genes (hox) exhibited a speedy return to normal expression
after only 1.5 h from the end of the treatment. Genes encoding
RA metabolic network components also exhibited abnormal
expression levels at t = 0, but their return to normal expression
was delayed beyond the time required for the RA targets to
reach normal expression. These observations suggest that the RA
metabolic network is altered through an RA-dependent feedback
regulatory mechanism to restore normal RA signaling and target
gene expression.
Multiple reports have described the RA-dependent regulation
of individual RA metabolic components. Most studies show
up-regulation of enzymes suppressing or reducing RA signaling
like CYP26A1, ADHFe1, and DHRS3, or down-regulation of RA

Hollemann et al., 1998; Reijntjes et al., 2005). Similar mild
defects were observed when we reduced RA levels by either
blocking the biosynthesis (DEAB treatment) or by targeting
this ligand for degradation (CYP26A1 overexpression), and
these observations are supported by multiple loss-of-function
studies describing mild developmental malformations induced
by RA signaling reduction (Blumberg et al., 1997; Sharpe and
Goldstone, 1997; Hollemann et al., 1998; Koide et al., 2001;
Janesick et al., 2014; Shabtai et al., 2017, 2018). Therefore, the
mild developmental defects observed by inducing physiological
fluctuations, increase or decrease in RA levels can be explained
by a compensatory transcriptional response, i.e., robustness.
An alternative explanation could be an intrinsic insensitivity
of RA-mediated gene regulation to physiological fluctuations.
Our results reject the latter explanation and support the
former model by showing activation of a compensatory
transcriptional robustness response. We show that one approach
to overwhelm this RA signaling robustness is to interfere with
the metabolic/signaling network at multiple steps (e.g., DEAB
and CYP26A1 induction) to hamper its ability to efficiently elicit
a feedback regulatory response.

The Retinoic Acid Robustness Response
Involves Autoregulatory Changes in the
Retinoic Acid Metabolic Network
To study the RA signaling robustness directly, we developed
an experimental protocol to induce transient, physiological
disturbances in RA levels. Our study supports the conclusion
that the RA metabolic and signaling network exhibits highly
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should involve the upregulation of RA suppressor activities
(DHRS3, ADHFe1, and CYP26A1), and the complementary
downregulation of RA producing enzymes (ALDH1A2 and
RDH10). This transcriptional response will exhibit a slight
delay due to the transcription, translation, and post-translational
modifications required.

producers (anabolic enzymes) like ALDH1A2 and RDH10 as a
result of RA treatment (Fujii et al., 1997; Hollemann et al., 1998;
Sonneveld et al., 1998; Chen et al., 2001; Dobbs-McAuliffe et al.,
2004; Strate et al., 2009; Sandell et al., 2012; Kam et al., 2013;
Shabtai et al., 2017). However, many of these studies utilized nonphysiological amounts of RA mostly in continuous treatments,
they were performed in multiple organisms, cell types, and
developmental stages, and some even obtained contradictory
results (Fujii et al., 1997; Niederreither et al., 1997; Hollemann
et al., 1998; Moss et al., 1998; Chen et al., 2001; DobbsMcAuliffe et al., 2004; Pavez Loriè et al., 2009; Strate et al., 2009;
Reijntjes et al., 2010; Kam et al., 2013; Topletz et al., 2015). Our
experimental design based on transcriptomic analysis together
with our description of the RA network during early/mid gastrula
allowed us to define the RA network-wide response to signaling
changes, in one organism, at a defined developmental stage, in
an unbiased manner by studying all the network components
expressed during gastrula Xenopus embryos.
We observed that some RA network components exhibit
an oscillatory behavior close to control expression levels,
probably as a result of the fine-tuning of the RA signal. Such
fine-tuning of the RA signal levels coupled to the inherent
delay in the transcriptional response could transiently result
in the inversion of the overall signaling direction, and an
oscillatory transcriptional behavior. In a few instances such
paradoxical observations of RA signaling outcome following RA
manipulation, i.e., overcompensation, have been reported (Lee
et al., 2012; D’Aniello et al., 2013; D’Aniello and Waxman, 2015;
Rydeen et al., 2015). These observations identify a very dynamic
feedback regulatory network continuously fine-tuning itself to
overcome perturbations.
The recovery kinetics analysis after conversion of the RNAseq
data to discretized patterns revealed that only 10 out of
the 27 possible expression patterns were represented in any
of the treatment or control samples, and only five patterns
were exhibited by a substantial number of genes (n > 100).
These observations suggest that RA-regulated genes, direct
or indirect, can only exhibit a limited number of possible
regulatory responses although intensity differences are possible.
Surprisingly, a comparative analysis of the discretized patterns
using our unbiased COMPACT approach (Kuttippurathu et al.,
2016) revealed that most genes (75.40%) responding to RA
manipulation and recovery exhibited a response to only
either increased or decreased RA levels. Only 48 genes out
of 553 (8.67%) exhibited the commonly expected reciprocal
responses to increased versus decreased RA levels. Many of
this small group of genes encode RA metabolism or signaling
components as part of the robustness response to maintain nonteratogenic RA levels.
The temporal delay in the return to normalcy between
RA targets and network components and the network-wide
response taking place at multiple levels provide an integrative
view of the feedback regulation and robustness response.
Initially, the response to RA changes will most probably be
managed by the actual enzymes and factors already present
in the cell. In parallel, the same RA changes will elicit a
self-regulatory transcriptional response which for increased RA
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Uneven Response to Increased Versus
Decreased Retinoic Acid Levels
Our study provides new insights on the network responses to
increased and decreased RA levels. One important conclusion
is that these responses are not simple opposites, but are
rather under different regulatory rules. As determined from
the unbiased discretized pattern analysis, a small proportion
of genes respond inversely to increased and decreased RA
levels. Otherwise, most of the RA-responsive genes respond
to one direction of RA change. This observation was further
supported by our relative ranking of the robustness of the
different embryo clutches based on the trajectory analysis. We
conclude that the RA auto-regulatory robustness response is
uneven based on: First, the limited number of RA target genes
that respond inversely to increased and decreased RA. Second,
the response to reduced signaling is activated by even a slight
RA reduction, while the response to increased RA is only
activated above a threshold. Also, the response to reduced
RA reaches an upper response limit, while the response to
increased RA appears to have a wider range. Notably, the network
responses show different thresholds depending on the direction
of the RA manipulation suggesting a high sensitivity to RA
reduction but a lower sensitivity to slight RA increase. Third,
the alignment of the robustness responses, hox changes, fitted
a diagonal with a negative slope with a significant correlation.
This negative slope suggested that while a clutch might very
efficiently deal with increased RA, i.e., high robustness, the
same clutch struggles to compensate for a reduction in RA,
i.e., low robustness, suggesting an intrinsic trade-off along the
lines of a Pareto multiobjective optimization (Miettinen, 1998;
Schuetz et al., 2012; Shoval et al., 2012; Tendler et al., 2015). In
the present case, the Pareto optimality suggests that improving
robustness toward one objective (e.g., decreased RA) can only
be achieved by degrading robustness toward another (increased
RA). Our results showing that some clutches achieve only
moderate robustness to positive and negative fluctuations in
RA, whereas others show uneven robustness, are consistent
with the notion of Pareto optimality of robustness to RA
fluctuations in the early embryo. Fourth, different clutches
with similar robustness can mount robustness responses by
incorporating different components of the RA network. The
transcriptomic and HT-qPCR analyses allowed us to perform a
detailed determination of the network components comprising
a robustness response across different clutches to uncover
its mechanism. The RA metabolic network includes multiple
enzymes with overlapping biochemical activities, e.g., ALDH1A1,
ALDH1A2, and ALDH1A3 enzymes that oxidize retinaldehyde
to produce RA (Kedishvili, 2016, 2013; Shabtai et al., 2016;
Ghyselinck and Duester, 2019). The enzymatic efficiencies and
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polymorphisms. Then, the developmental malformations arising
from environmental insults on RA signaling largely depend on
genetic polymorphisms which will determine the composition,
efficiency and threshold of the response and the actual network
components comprising such a response.

expression patterns including location, timing, and intensity may
be different across the enzymes (Chen et al., 2001; Blentic et al.,
2003; Romand et al., 2004; Lupo et al., 2005; Shabtai et al., 2016).
The enzymes CYP26A1, B1, and C1, or DHRS3, ADHFe1, and
RDH14 function to prevent excessive RA signaling (Hollemann
et al., 1998; Sonneveld et al., 1998; Belyaeva et al., 2008, 2017;
Shabtai et al., 2017). These redundant enzymes and factors can
help establish a robustness response using different components
(Figures 8D,E, 9). Finally, genetic polymorphisms can probably
partially explain the different responses between clutches of our
outbred experimental model, Xenopus laevis (Savova et al., 2017).
Formally, technical issues could account for some variability.
The six clutches analyzed by HT-qPCR, six clutches analyzed by
RNAseq, and the five clutches from the qPCR analysis showed
a similar distribution of the same variability supporting the
possible involvement of genetic polymorphisms. We mined the
Savova et al. (2017) data identifying multiple polymorphisms in
RA network components (Supplementary Table 3), supporting
the potential contribution of genetic variability to the differential
and uneven robustness across clutches.
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